Table 1 Clinicopathological features of the 94 gastric cancer cases. Significant values are in bold.
Parameter | Number/% (n = 94) | p value |
|---|---|---|
Median age (standard deviation) | 69 years (± 9.14) | – |
Gender | ||
Male | 73/77.6% | 0.013 |
Female | 21/22.4% | |
Tumor location | ||
Proximal | 28/29.79% | 0.038 |
Distal | 66/70.21% | |
Histologic type and grade of differentiation (G) | ||
G1/2 adenocarcinoma | 46/48.9% | 0.063 |
G3 adenocarcinoma | 25/26.6% | |
Poorly cohesive (diffuse) carcinoma | 23/24.5% | |
Depth of invasion (pT stage) | ||
pT1 | 10/10.6% | 0.009 |
pT2 | 6/6.4% | |
pT3 | 23/24.5% | |
pT4a | 42/44.7% | |
pT4b | 13/13.8 | |
Regional lymph node status (pN stage) | ||
pN0 | 26/27.6 | 0.033 |
pN1–3 | 68/72.4% | |
Distant metastases (pM stage) | ||
M0 | 77/81.9% | 0.008 |
M1 | 17/18.1% | |
Dukes-MAC-like stage | ||
A1 (pT1N0) | 9/9.6% | 0.056 |
A2 (pT1N1–3) | 1/1.1% | |
B1 (pT2N0) | 6/6.4% | |
B2(pT2N1–3) | – | |
C1 (pT3N0) | 5/5.3% | |
C2 (pT3N1–3) | 18/19.2% | |
D (pT4N0–3) | 55/58.4% | |
